Pharma Science Revives Ayurveda with Zero Investment Plan

Pharma Science, a leader in India's Ayurvedic healthcare industry, is revolutionizing natural wellness with clinically proven, patented products and an open business model...

Venus Remedies Taps Ekta S. Chaudhary to Lead Venus Foundation

Venus Remedies has declared the appointment of Ekta S. Chaudhary as the new Chairperson of the Venus Foundation, marking a major step in the company’s commitment to social responsibility.

ProBioGen & Polpharma Biologics team up for biosimilar cell lines

Cell line development expert ProBioGen has declared the partnership with biotech firm Polpharma Biologics to deliver cell line for one of the biosimilar molecules being developed by Polpharma...

Indian Drugmakers Face Heat as FDA Expands Surprise Global Inspections

In an effort to improve consumer safety and reinforce regulatory compliance, the US Food and Drug Administration (FDA) announced on Tuesday that it will raise the frequency of surprise inspections at foreign manufacturing facilities.

DTAB Recommends All Antimicrobials Be Treated as New Drugs to Tackle AMR

In a major regulatory move aimed at curbing antimicrobial resistance (AMR), the Drugs Technical Advisory Board (DTAB) has recommended that all antimicrobials should be permanently classified as...

Lupin Launches Eslicarbazepine Acetate in U.S. with 180-Day Exclusivity

Global pharmaceutical company Lupin Limited has announced the launch of Eslicarbazepine Acetate Tablets in the U.S. market, following the approval of its Abbreviated New Drug Application (ANDA) by the U...

Alembic Pharma Eyes FY26 Growth with Domestic Surge and Global Push

Alembic Pharmaceuticals has raised its expectation margin for FY26, with increased domestic sales, and international expansion. The CFO of the company, R.K.Baheti informed Moneycontrol that the company recorded higher E...

Indian Pharma Faces US Setback Amid Push for Domestic Drug Manufacturing

Indian pharmaceutical companies may encounter significant hurdles in the US following President Donald Trump’s new executive orders aimed at promoting domestic drug production...

NKure & CRISPR Partner to Advance CTX112 Cancer Therapy in India

NKure Therapeutics Private Limited, a Bengaluru-based cell and gene therapy startup committed to advancing innovative cell therapies, and CRISPR Therapeutics (Nasdaq: CRSP), a pioneer in gene-based medicines, today announced a strategic...

India Updates Biosimilar Rules, Focuses on 3Rs & Analytics

Comments have been invited from the stakeholders by the Central Drugs standard control organization (CDSCO) on the revised guidelines on biosimilars with updated requirements for marketing authorizations in the country

on the deck


Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.